Results 111 to 120 of about 13,448 (142)

The alpha-gal syndrome: Understanding the role of tick bites, and the delays in severe anaphylaxis. [PDF]

Allergy Asthma Proc
Platts-Mills TAE, Dunaway CA, Gangwar RS, Workman LJ, Wilson JM.   +4 more
europepmc   +1 more source

Neutralizing human monoclonal antibodies to poliovirus map to the receptor binding site. [PDF]

Nat Commun
Waddey BT, Charnesky AJ, Faust JE, DiNunno NM, Puligedda RD, Cho SH, Bator CM, Dong SD, Mahmood K, Chumakov KM, Dessain SK, Hafenstein SL.   +11 more
europepmc   +1 more source

Discovery and Structural Characterization of a Highly Protective Neutralizing Antibody Targeting the Mpox Virus A35R Protein. [PDF]

MedComm (2020)
Bai S, Song S, Wang X, Xiao Y, Long Y, Wu F, Wang F, Fan Z, Xu J, He M, Lu H.   +10 more
europepmc   +1 more source

Different Fc scaffolds enhance the breadth of <i>in vitro</i> neutralization of the same Fab against different Rotavirus strains. [PDF]

Front Immunol
Miranda-Echagüe MR, Vezzani G, Morandi E, Della Peruta M, Scordio M, Reyes TAC, Oldrini D, Iturriza-Gómara M, Loomis RJ, Rossi O.   +9 more
europepmc   +1 more source

Affinity- and epitope-dependent pathogenicity of GM-CSF autoantibodies in patients with autoimmune pulmonary alveolar proteinosis. [PDF]

Nat Commun
Futami S, Kawai C, Kishikawa JI, Hirose M, Kida H, Wang PH, Yamashita K, Ishikawa F, Kato T, Inoue Y, Kumanogoh A, Kurosaki T, Inoue T.   +12 more
europepmc   +1 more source

Curbing Autoimmunity: A New Fab Fragment Targeting CD40-CD40L Halts B-Cell Activation and Differentiation. [PDF]

Eur J Immunol
Pedersen K, Green K, Kristoffersen EL, Schinkel T, Hansen AG, Palarasah Y, Rovsing AB, Andersen ES, Valero J, Civit L, Laursen NS, Troldborg A, Degn SE, Thiel S.   +13 more
europepmc   +1 more source

Partial downregulation of platelet glycoprotein VI by low affinity antibodies confers sustained and safe antithrombotic protection. [PDF]

Signal Transduct Target Ther
Navarro S, Beck S, Bonfiglio SI, Cuenca-Zamora EJ, Weiß LJ, Kuijpers M, Heemskerk J, Stegner D, Nieswandt B.   +8 more
europepmc   +1 more source

Discovery, development, and characterization of SPY002 and SPY072, two novel extended half-life monoclonal antibodies targeting TL1A: in vitro properties, in vivo pharmacology, pharmacokinetics, and preclinical safety. [PDF]

MAbs
Siegel M, Zhu E, Rios D, Kang BH, McNally J, Kennedy M, Hew K, Patel P, Ballew O, Giles DH, Lewis EMA, LaFountaine J, Oh J, Friedman JR, Rose MJ, Shaheen H, Spencer AG.   +16 more
europepmc   +1 more source

HMB-002: a monovalent antibody that elevates circulating VWF and FVIII levels for treatment of von Willebrand disease. [PDF]

Blood Adv
Häger M, Zivkovic M, Gandhi PS, Rasmussen C, Bonvoisin C, Harrison RA, Poulsen E, Huskens D, Roest M, Ferrara F, Naretto A, Renaud L, Olsen OH, Eskesen NO, Holten-Andersen L, Malladi R, Rea CJ, Sørensen B, Urbanus RT, Østergaard H.   +19 more
europepmc   +1 more source

Insights into the structural differences between homo- and heterodimers enriched from a cocktail of monoclonal antibodies against SARS-CoV-2. [PDF]

Sci Rep
Nguyen JB, Liu S, Yan Y, Choudhary D, Oberholtzer ZR, Zhou Y, Skow DJ, Sheikh M, Sandu C, Wang S, Li N, Franklin MC, Rosconi MP, Pyles EA.   +13 more
europepmc   +1 more source